2008
DOI: 10.1016/j.bbalip.2008.04.016
|View full text |Cite
|
Sign up to set email alerts
|

Modification of LDL with oxidized 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphorylcholine (oxPAPC) results in a novel form of minimally modified LDL that modulates gene expression in macrophages

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
12
0

Year Published

2009
2009
2020
2020

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 14 publications
(12 citation statements)
references
References 31 publications
0
12
0
Order By: Relevance
“…Several groups have shown that LDL supplemented with Ox-PAPC or vesicles supplemented with fragmented a/b unsaturated fatty acids at the sn-2 position, such as KOdiA or HODA PC, bind to CD36 (2,20). In these experiments, as little as 0.3 mol% of HDdiA PC was sufficient to cause CD36 binding.…”
Section: Macrophagesmentioning
confidence: 64%
See 1 more Smart Citation
“…Several groups have shown that LDL supplemented with Ox-PAPC or vesicles supplemented with fragmented a/b unsaturated fatty acids at the sn-2 position, such as KOdiA or HODA PC, bind to CD36 (2,20). In these experiments, as little as 0.3 mol% of HDdiA PC was sufficient to cause CD36 binding.…”
Section: Macrophagesmentioning
confidence: 64%
“…Mechanisms of induction of pro-apoptotic pathways by OxPL have been reviewed recently (28). However, in atherosclerotic lesions, where macrophages are constantly exposed to high levels of OxPLs, macrophages survive for surprisingly long periods of time, despite the toxic environment, implying the upregulation of survival mechanisms, such as antioxidant pathways and phase II detoxification genes, some of which have been observed (12,20).…”
Section: Macrophagesmentioning
confidence: 99%
“…Oxidized LDL and DiI-labeled oxLDL were prepared from pooled human plasma and labeled as described. 39 …”
Section: Methodsmentioning
confidence: 99%
“…45 In the current study we did not measure oxPAPC in LDL fraction although prior studies have demonstrated increased oxPAPC in circulating lipoproteins including LDL and HDL. 46, 47 Although oxPAPC may not be the major component of oxLDL or oxidized lipids within plaque, it certainly may represent an additional oxidation product that is delivered via scavenger receptors and may accumulate within atherosclerosis. Additionally the presence of oxPAPC may result in pro-inflammatory effects within the vascular wall.…”
Section: Discussionmentioning
confidence: 99%